A rep visit is your costliest touchpoint, and it fades within weeks. Learn how a planned digital sequence turns that attention into a lasting brand position.
A rep visit is the costliest interaction in the entire marketing mix. Preparation, travel, salary, and the doctor's own time all go into securing just a few minutes of genuinely undivided attention.
Those minutes are genuinely valuable. A doctor listening to a rep is more engaged than they will ever be with any digital asset that brand produces all year, because a person is asking for their attention rather than an algorithm.
Then the rep leaves, and nothing follows. Within a fortnight the doctor recalls meeting someone from a company, but not which point was made, and often not which brand made it either.
In our work across the region we consistently see strong in-person engagement scores followed by almost no recall weeks later, which means the most expensive touchpoint available produced no lasting position at all.
Attention created by a visit does not stay reserved for the brand that created it. It decays quickly, and while it decays, every other message competing for that same doctor is still arriving on schedule.
A competitor with a weaker visit and a stronger digital follow-up ends up better positioned in the end. Not because their argument was stronger, but because theirs was simply the last one the doctor encountered on that subject.
The visit did the difficult part of the work. It earned attention that no email or advertisement could have earned on its own and then handed that attention over to whoever happened to show up next.
Doctors retain the interaction, not the argument. They remember a pleasant conversation, a person, sometimes a company name, and almost never the specific clinical point that took twenty minutes to explain.
The point survives only if it appears again, in a different form, while the memory of that conversation is still active. Without a second appearance, it fades exactly like any other unrepeated detail would.
The follow-up is not a courtesy message. It is the mechanism that converts a visit into a position, and it should be planned before the visit rather than improvised afterwards.
Four touchpoints cover most sequences, and each one carries the same argument in the form its channel is built for.
Not every doctor needs every channel in the sequence. Someone active on a professional feed but rarely on messaging should receive the article, not a message that will never actually be opened.
Digital Market Intelligence & Research identifies which channels each doctor genuinely uses, so the follow-up reaches them where they already are rather than where the sequence assumed they would be.
Omnichannel Strategy & Consultation designs the sequence itself, defining what follows the visit in week one, what follows in week two, and which channel carries which part of the message.
Creative & Digital Production builds those follow-up assets well in advance, so the sequence runs on schedule rather than depending on a rep remembering to send something between two appointments.
Every channel after the visit must extend the same argument the rep made. A doctor encountering three different value propositions in a week trusts none of them, because the brand reads as unsettled rather than reinforced.
Brand Strategy & Development fixes what stays constant across the sequence and what adapts by channel, so the email, the article, and the advertisement all trace back to the point the rep actually made.
Digital opinion leaders extend that same argument into peer conversation, reaching doctors who trust a colleague's assessment far more than they trust any branded asset.
Assign clear ownership for each touchpoint in the sequence before the first visit ever happens. A follow-up that depends on someone remembering to send it is a follow-up that will not survive a single busy quarter.
A rep visit is the costliest interaction in the entire marketing mix. Preparation, travel, salary, and the doctor's own time all go into securing just a few minutes of genuinely undivided attention.
Those minutes are genuinely valuable. A doctor listening to a rep is more engaged than they will ever be with any digital asset that brand produces all year, because a person is asking for their attention rather than an algorithm.
Then the rep leaves, and nothing follows. Within a fortnight the doctor recalls meeting someone from a company, but not which point was made, and often not which brand made it either.
In our work across the region we consistently see strong in-person engagement scores followed by almost no recall weeks later, which means the most expensive touchpoint available produced no lasting position at all.
Attention created by a visit does not stay reserved for the brand that created it. It decays quickly, and while it decays, every other message competing for that same doctor is still arriving on schedule.
A competitor with a weaker visit and a stronger digital follow-up ends up better positioned in the end. Not because their argument was stronger, but because theirs was simply the last one the doctor encountered on that subject.
The visit did the difficult part of the work. It earned attention that no email or advertisement could have earned on its own and then handed that attention over to whoever happened to show up next.
Doctors retain the interaction, not the argument. They remember a pleasant conversation, a person, sometimes a company name, and almost never the specific clinical point that took twenty minutes to explain.
The point survives only if it appears again, in a different form, while the memory of that conversation is still active. Without a second appearance, it fades exactly like any other unrepeated detail would.
The follow-up is not a courtesy message. It is the mechanism that converts a visit into a position, and it should be planned before the visit rather than improvised afterwards.
Four touchpoints cover most sequences, and each one carries the same argument in the form its channel is built for.
Not every doctor needs every channel in the sequence. Someone active on a professional feed but rarely on messaging should receive the article, not a message that will never actually be opened.
Digital Market Intelligence & Research identifies which channels each doctor genuinely uses, so the follow-up reaches them where they already are rather than where the sequence assumed they would be.
Omnichannel Strategy & Consultation designs the sequence itself, defining what follows the visit in week one, what follows in week two, and which channel carries which part of the message.
Creative & Digital Production builds those follow-up assets well in advance, so the sequence runs on schedule rather than depending on a rep remembering to send something between two appointments.
Every channel after the visit must extend the same argument the rep made. A doctor encountering three different value propositions in a week trusts none of them, because the brand reads as unsettled rather than reinforced.
Brand Strategy & Development fixes what stays constant across the sequence and what adapts by channel, so the email, the article, and the advertisement all trace back to the point the rep actually made.
Digital opinion leaders extend that same argument into peer conversation, reaching doctors who trust a colleague's assessment far more than they trust any branded asset.
Assign clear ownership for each touchpoint in the sequence before the first visit ever happens. A follow-up that depends on someone remembering to send it is a follow-up that will not survive a single busy quarter.
A visit buys attention, and without follow-up the brand gives that attention away.
A visit buys attention, and without follow-up the brand gives that attention away.